-Reuters
Procaps Gr Q3 Sales $110.00M
Procaps Gr (NASDAQ:PROC) reported quarterly sales of $110.00 million which missed the analyst consensus estimate of $123.90 million by 11.22 percent.
Related Posts
Restaurant Chain CAVA To Start Trading On NYSE Today: What You Should Know
Washington D.C.-based CAVA Group, Inc. (NYSE:CAVA) is scheduled to start trading on the New York Stock Exchange on…
How Does Apple’s Vision Pro Compare With Meta’s Quest 3?
The battle of augmented reality or AR and virtual reality or VR headsets heats up as Apple Inc.’s (NASDAQ:AAPL) Vision Pro and Meta…
Nuvectis Pharma Announces Data for NXP800 In A Preclinical Model Of ARID1a-Mutated Gastric Carcinoma
FORT LEE, N.J., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. ("Nuvectis", "Company"), a biopharmaceutical company focused on the development of innovative precision medicines for the